Guideline document

Your browser can't display PDFs inline. Open the guideline in a new tab.

This guideline is provided for in-page reading only. Please contact the publishing organization for downloadable copies.

130 Views
0 Likes
0 Shares
0 Comments

StayCurrentMD

View profile →

Clinical Guideline

Gastrografin for Adhesive Small Bowel Obstruction (SBO)

Topic overview

Evidence-based protocol from Cincinnati Children's Hospital for using water-soluble contrast (Gastrografin) in the conservative management of adhesive small bowel obstruction in pediatric patients. Guidelines synthesize findings from multiple studies demonstrating diagnostic and therapeutic benefits of contrast administration.

Key Takeaways

  • Gastrografin protocol requires NGT decompression for ≥1 hour before administration, then clamping for 8-10 hours post-dose.
  • Dosing: ≥8 years gets 100cc gastrografin + 100cc water; <8 years gets 50cc gastrografin + 50cc water.
  • Contrast reaching cecum by 10 hours predicts successful non-operative management; reassess at 24 hours if negative.
  • Exclude patients with strangulation signs, peritonitis, active malignancy, or non-adhesive SBO from protocol.
  • Serial q4h exams mandatory; unclamp NGT to suction if patient becomes nauseated or vomits during observation period.

Keywords

Hashtags

Full guideline text

Click "Show full text" to view the full text (2294 characters)

How to cite: GlobalCastMD. Gastrografin for Adhesive Small Bowel Obstruction (SBO). GlobalCastMD Medical Library. https://library.globalcastmd.com/guideline/1843

Comments

Loading comments...